Dr. Andreas Roos wins Emerging Myologist of the Year Prize at WMS 2023

Published: 17 October 2023

We are excited to congratulate Dr. Andreas Roos on winning the World Muscle Society’s (WMS) President’s Prize for Emerging Myologist of the Year!  

This award (formerly the President’s Prize for Young Myologist of the Year) recognizes outstanding contributions and innovation from an up-and-coming researcher in the field of myology. This year’s award highlights Dr. Roos’s exceptional portfolio of recent work, commending in particular his presentation at the conference on the identification of FILIP1 variants as a novel genetic cause for a neuropediatric disease with muscle involvement. Dr. Roos’s prolific output has resulted in a career total of almost 150 publications to date, and the FILIP1 manuscript is the latest of over 50 that Dr. Roos has published together with our group.  

Dr. Andreas Roos’s publication “Bi-allelic variants of FILIP1 cause congenital myopathy dysmorphism and neurological defects”

Dr. Roos is based at the Department of Neuropaediatrics of the Universitätsklinikum Essen in Germany and holds an adjunct professorship at uOttawa. He has been a long-time collaborator with our lab on joint projects on myotonic dystrophy, GNE myopathy, gene discovery and proteomic profiling in neuromuscular disease and has also consistently been involved in international research collaborations spanning a variety of diseases and techniques.

Congratulations Dr. Andreas Roos, World Muscle Society Emerging Myologist of the Year!

Dr. Andreas Roos receiving Emerging Myologist of the Year prize at World Muscle Society congress 2023.

Photo by World Muscle Society / World Muscle Society Congress 2023.

Dr. Andreas Roos receiving award on WMS 2023 stage, with text reading Congratulaions Dr. Andreas Roos, WMS President's Prize for Emerging Myologist of the Year 2023.

Read next...

We are hiring a new clinical research coordinator!

Lochmüller Research Group Hiring Clinical Trial Coordinator

Due to recent funding success and expansion of our clinical trials team we have a need for a highly motivated Research Coordinator that will assist...
First participant screened in global CMS natural history study

The Ottawa Neuromuscular Centre screens first participant in the world for a multinational congenital myasthenic syndrome natural history study

The neuromuscular centre at The Ottawa Hospital is excited to announce that we are the first site globally to screen a participant for the multinational...
Copy of Lochmuller Lab - PhD opportunity (LLab)

Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO...
New Publication - Leading global expert in DMD and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for biphosphonate therapy in glucocorticoid-treated patients with Duchenne Muscular Dystrophy in Neurology, with Dr. Hanns Lochmüller as a co-author.

New Publication: Bisphosphonates in Glucocorticoid-Treated Patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence

Leading global expert in Duchenne Muscular Dystrophy (DMD) and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for bisphosphonate therapy in...
text reding new clinical trial opportunities

New Clinical Trial Opportunities for Children and Adults in Ottawa

Our clinical research team is excited to share five new clinical trials activated across both pediatric and adult sites in Ottawa, CHEO and TOH. We...
Lochmüller Lab members gather for a group photo at the Ottawa NMD poster session.

Lochmüller Lab at Ottawa NMD 2023

This September 7th to 9th the University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD) hosted the 6th Ottawa International Conference on Neuromuscular Disease...